Abacus LifeABL
ABL
About: Abacus Life Inc is a vertically integrated alternative asset manager specializing in investing in life insurance products throughout the lifecycle of a life insurance policy.
Employees: 102
0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
11,300% more call options, than puts
Call options by funds: $342K | Put options by funds: $3K
156% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 9
63% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 8
30% more capital invested
Capital invested by funds: $102M [Q2] → $133M (+$30.9M) [Q3]
11% more funds holding
Funds holding: 45 [Q2] → 50 (+5) [Q3]
1.99% more ownership
Funds ownership: 15.63% [Q2] → 17.62% (+1.99%) [Q3]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$13
74%
upside
Avg. target
$13.83
86%
upside
High target
$15
101%
upside
3 analyst ratings
3 positive
100%
0 neutral
0%
0 negative
0%
B. Riley Securities Matt Howlett 26% 1-year accuracy 5 / 19 met price target | 101%upside $15 | Buy Maintained | 7 Jan 2025 |
Piper Sandler Crispin Love 61% 1-year accuracy 17 / 28 met price target | 75%upside $13 | Overweight Reiterated | 8 Nov 2024 |
Northland Capital Markets Mike Grondahl 63% 1-year accuracy 27 / 43 met price target | 81%upside $13.50 | Outperform Initiated | 24 Oct 2024 |
Financial journalist opinion
Positive
Zacks Investment Research
3 weeks ago
Abacus Life, Inc. (ABL) Upgraded to Strong Buy: Here's What You Should Know
Abacus Life, Inc. (ABL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Positive
Zacks Investment Research
4 weeks ago
Wall Street Analysts Think Abacus Life, Inc. (ABL) Could Surge 86.27%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 86.3% in Abacus Life, Inc. (ABL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Neutral
GlobeNewsWire
1 month ago
Abacus Life Completes Acquisition of FCF Advisors
ORLANDO, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today announced it has completed the acquisition of FCF Advisors (“FCF”), a New York-based asset manager and index provider specializing in free cash flow-focused investment strategies. The acquisition of FCF, which currently has approximately $850 million in assets under management, constitutes a significant milestone in Abacus' ongoing expansion of ABL Wealth and its suite of products.
Neutral
GlobeNewsWire
1 month ago
Abacus Life Completes Acquisition of Carlisle Management Company S.C.A.
ORLANDO, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today announced it has completed the acquisition of Carlisle Management Company S.C.A. (“Carlisle”), a leading Luxembourg-based investment fund manager in the life settlement space with over U.S. $2 billion in assets under management. The Carlisle acquisition marks a key milestone in Abacus's stated strategy to drive long-term growth and diversify its value proposition through expanded global alternative asset-management offerings.
Neutral
GlobeNewsWire
1 month ago
Abacus Life Targets Close of the Acquisition of Carlisle Management Company S.C.A. for December 2, 2024 with Receipt of Regulatory Non-Objection
ORLANDO, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, announced it has received regulatory non-objection from the Luxembourg Commission de Surveillance du Secteur Financier (“CSSF”) for the acquisition of Carlisle Management Company S.C.A. (“Carlisle”), a leading Luxembourg-based investment fund manager in the life settlement space.
Neutral
GlobeNewsWire
1 month ago
Abacus Life Announces Closing of Public Offering of 12,500,000 Shares of Common Stock
ORLANDO, Fla., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the closing of its oversubscribed underwritten public offering of 12,500,000 shares of its common stock, consisting of 10,000,000 shares of its common stock sold by the Company and 2,500,000 shares of common stock sold by certain stockholders of the Company (the “Selling Stockholders”) at the public offering price of $8.00 per share. The gross proceeds raised in the offering, before underwriting discounts and commissions and estimated expenses of the offering, were approximately $100 million, of which approximately $80 million was raised in the primary offering by the Company and approximately $20 million was paid in connection with the sale of shares by the Selling Stockholders.
Positive
MarketBeat
1 month ago
Abacus Life's CEO on Cracking the Code of Longevity Returns
Abacus Life, Inc. NASDAQ: ABL is a global alternative asset manager specializing in a unique niche within the financial markets. The company acquires and manages life insurance policies.
Neutral
GlobeNewsWire
1 month ago
Abacus Life Announces Pricing of Public Offering of Common Stock
ORLANDO, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the pricing of its underwritten public offering of 12,500,000 shares of its common stock, including 10,000,000 shares of common stock being offered by the Company and 2,500,000 shares of common stock being offered by certain stockholders of the Company (the “Selling Stockholders”), at a price to the public of $8.00 per share. In connection with the offering, the Company also granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock from the Company and up to an additional 375,000 shares of common stock from the Selling Stockholders at the public offering price. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $100 million, excluding any exercise of the underwriters' option to purchase additional shares.
Neutral
GlobeNewsWire
1 month ago
Abacus Life Announces Proposed Public Offering of Common Stock
ORLANDO, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in leveraging longevity and actuarial technology to offer uncorrelated investment opportunities, today announced the commencement of an underwritten public offering of 12,500,000 shares of its common stock, including 10,000,000 shares of common stock to be sold by the Company and 2,500,000 to be sold by certain stockholders of the Company (the “Selling Stockholders”). The Company and the Selling Stockholders also expect to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock from the Company and up to an additional 375,000 shares of common stock from the Selling Stockholders.
Positive
Zacks Investment Research
1 month ago
Wall Street Analysts Believe Abacus Life, Inc. (ABL) Could Rally 59.48%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 59.5% in Abacus Life, Inc. (ABL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Charts implemented using Lightweight Charts™